Peer Support & Storytelling for COPD
(ImPReSS-COPD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to assist people with COPD, a lung condition that makes breathing difficult, in adhering to pulmonary rehabilitation (PR) programs after a flare-up. Researchers will compare three approaches: usual care, watching video stories from others who have successfully completed PR (storytelling), and phone support from a peer who has faced similar challenges (telephonic peer coaching). Individuals recently treated for a COPD flare-up and open to trying PR may find this trial suitable. Participants must speak English, have a working phone, and be willing to watch videos or join calls. As an unphased trial, this study offers a unique opportunity to explore innovative support methods for managing COPD.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on participation in pulmonary rehabilitation and peer support.
What prior data suggests that these strategies are safe for increasing patient participation in pulmonary rehabilitation?
Research has shown that phone-based peer coaching is generally well-received by people with COPD. The PELICAN Study found that this coaching improved patients' use of oxygen at home and enhanced their overall health. No major safety concerns arose, and patients found the coaching helpful.
Studies on similar video call programs have shown high patient satisfaction. Although some experienced technical problems, these did not affect safety. Patients appreciated hearing stories that matched their own experiences.
Both phone coaching and storytelling are non-invasive, meaning they don't involve medicine or physical procedures, and are considered safe for most people. Reports of major side effects from these methods have not emerged, making them promising options for those interested in joining a trial.12345Why are researchers excited about this trial?
Researchers are excited about Peer Support and Storytelling for COPD because these methods offer a fresh approach to managing the condition. Unlike traditional treatments that often focus on medications and pulmonary rehabilitation, these techniques emphasize personal connection and narrative. Peer coaching provides patients with relatable support from someone who has faced similar challenges, helping to motivate and guide them through their COPD management. Storytelling, on the other hand, leverages the power of shared experiences to inspire patients, showing them real-life examples of overcoming barriers. These approaches aim to enhance patient engagement and adherence, potentially leading to better health outcomes and improved quality of life for those living with COPD.
What evidence suggests that this trial's treatments could be effective for COPD?
Research has shown that phone-based peer coaching, one of the interventions in this trial, helps people with COPD manage their condition better. Patients who received phone coaching often gained more knowledge about their disease and how to handle it. Similarly, storytelling, another intervention tested in this trial, improves care for COPD patients by helping them connect with others' experiences and overcome challenges. Using storytelling in healthcare, known as narrative medicine, has effectively managed COPD. Both methods aim to encourage participation in pulmonary rehabilitation programs, which have been proven to improve the quality of life for people with COPD.36789
Who Is on the Research Team?
Peter Lindenauer, MD, MSc
Principal Investigator
Baystate Health
Are You a Good Fit for This Trial?
This trial is for individuals over 40 with COPD who've been treated for an exacerbation and referred to pulmonary rehabilitation (PR). Participants must be willing to engage in peer coaching calls, watch storytelling videos, have a working phone, and communicate in English. Those not eligible or unwilling to attend PR, in hospice care, living in long-term facilities, or who have already completed significant PR are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
R61 Phase
Recruit and train peer coaches, recruit storytellers, capture narratives on video, finalize protocol, trial infrastructure, and pilot recruitment strategy
R33 Phase
Recruit 305 adults treated for exacerbation of COPD, randomize them to Enhanced Usual Care, eUC + Storytelling, or eUC + Peer Support, and evaluate effectiveness at promoting participation in PR at 6 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Storytelling
- Telephonic Peer Coaching
Find a Clinic Near You
Who Is Running the Clinical Trial?
Baystate Medical Center
Lead Sponsor
University of Michigan
Collaborator
University of Massachusetts, Worcester
Collaborator
COPD Foundation
Collaborator
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator